148 related articles for article (PubMed ID: 7953636)
1. The effects of amfonelic acid, a dopamine uptake inhibitor, on methamphetamine-induced dopaminergic terminal degeneration and astrocytic response in rat striatum.
Pu C; Fisher JE; Cappon GD; Vorhees CV
Brain Res; 1994 Jun; 649(1-2):217-24. PubMed ID: 7953636
[TBL] [Abstract][Full Text] [Related]
2. Methamphetamine and human immunodeficiency virus protein Tat synergize to destroy dopaminergic terminals in the rat striatum.
Theodore S; Cass WA; Maragos WF
Neuroscience; 2006 Feb; 137(3):925-35. PubMed ID: 16338084
[TBL] [Abstract][Full Text] [Related]
3. Protective effects of MK-801 on methamphetamine-induced depletion of dopaminergic and serotonergic terminals and striatal astrocytic response: an immunohistochemical study.
Pu C; Vorhees CV
Synapse; 1995 Feb; 19(2):97-104. PubMed ID: 7725247
[TBL] [Abstract][Full Text] [Related]
4. Damage to dopaminergic nerve terminals in mice by combined treatment of intrastriatal malonate with systemic methamphetamine or MPTP.
Albers DS; Zeevalk GD; Sonsalla PK
Brain Res; 1996 Apr; 718(1-2):217-20. PubMed ID: 8773791
[TBL] [Abstract][Full Text] [Related]
5. The effects of monoamine uptake inhibitors and methamphetamine on neostriatal 6-hydroxydopamine (6-OHDA) formation, short-term monoamine depletions and locomotor activity in the rat.
Marek GJ; Vosmer G; Seiden LS
Brain Res; 1990 May; 516(1):1-7. PubMed ID: 2142010
[TBL] [Abstract][Full Text] [Related]
6. Single or multiple injections of methamphetamine increased dopamine turnover but did not decrease tyrosine hydroxylase levels or cleave caspase-3 in caudate-putamen.
Pereira FC; Lourenço ES; Borges F; Morgadinho T; Ribeiro CF; Macedo TR; Ali SF
Synapse; 2006 Sep; 60(3):185-93. PubMed ID: 16739116
[TBL] [Abstract][Full Text] [Related]
7. Selective inhibition of cyclooxygenase-2 exacerbates methamphetamine-induced dopamine depletion in the striatum in rats.
Zhang X; Dong F; Mayer GE; Bruch DC; Ren J; Culver B
Neuroscience; 2007 Dec; 150(4):950-8. PubMed ID: 17988800
[TBL] [Abstract][Full Text] [Related]
8. Role of the dopamine uptake carrier in the neurochemical response to methamphetamine: effects of amfonelic acid.
Schmidt CJ; Gibb JW
Eur J Pharmacol; 1985 Feb; 109(1):73-80. PubMed ID: 2581794
[TBL] [Abstract][Full Text] [Related]
9. Developmental dissociation of methamphetamine-induced depletion of dopaminergic terminals and astrocyte reaction in rat striatum.
Pu C; Vorhees CV
Brain Res Dev Brain Res; 1993 Apr; 72(2):325-8. PubMed ID: 8097974
[TBL] [Abstract][Full Text] [Related]
10. Nicotinamide attenuates methamphetamine-induced striatal dopamine depletion in rats.
Huang NK; Wan FJ; Tseng CJ; Tung CS
Neuroreport; 1997 May; 8(8):1883-5. PubMed ID: 9223070
[TBL] [Abstract][Full Text] [Related]
11. Effect of methamphetamine on glutamate-positive neurons in the adult and developing rat somatosensory cortex.
Pu C; Broening HW; Vorhees CV
Synapse; 1996 Aug; 23(4):328-34. PubMed ID: 8855518
[TBL] [Abstract][Full Text] [Related]
12. Deprenyl induces GFAP immunoreactivity in the intact and injured dopaminergic nigrostriatal system but fails to counteract axotomy-induced degenerative changes.
Revuelta M; Venero JL; Machado A; Cano J
Glia; 1997 Oct; 21(2):204-16. PubMed ID: 9336235
[TBL] [Abstract][Full Text] [Related]
13. Effects of estrogen and related agents upon methamphetamine-induced neurotoxicity within an impaired nigrostriatal dopaminergic system of ovariectomized mice.
Liu B; Dluzen DE
Neuroendocrinology; 2006; 83(5-6):295-302. PubMed ID: 16926530
[TBL] [Abstract][Full Text] [Related]
14. Reduced degeneration of dopaminergic terminals and accentuated astrocyte activation by high dose methamphetamine administration in nociceptin receptor knock out mice.
Sakoori K; Murphy NP
Neurosci Lett; 2010 Jan; 469(3):309-13. PubMed ID: 20025929
[TBL] [Abstract][Full Text] [Related]
15. Dopamine uptake inhibitors block long-term neurotoxic effects of methamphetamine upon dopaminergic neurons.
Marek GJ; Vosmer G; Seiden LS
Brain Res; 1990 Apr; 513(2):274-9. PubMed ID: 2140952
[TBL] [Abstract][Full Text] [Related]
16. Epothilone D prevents binge methamphetamine-mediated loss of striatal dopaminergic markers.
Killinger BA; Moszczynska A
J Neurochem; 2016 Feb; 136(3):510-25. PubMed ID: 26465779
[TBL] [Abstract][Full Text] [Related]
17. Dopamine transporter as a marker of neuroprotection in methamphetamine-lesioned mice treated acutely with estradiol.
D'Astous M; Gajjar TM; Dluzen DE; Di Paolo T
Neuroendocrinology; 2004; 79(6):296-304. PubMed ID: 15249736
[TBL] [Abstract][Full Text] [Related]
18. Methamphetamine-induced modification of dopamine metabolism in cultured striatal astrocytes.
Kita T; Philbert MA; Wagner GC; Huang J; Lowndes HE
Pharmacol Toxicol; 1998 Jul; 83(1):36-9. PubMed ID: 9764424
[TBL] [Abstract][Full Text] [Related]
19. Acute effects of estrogen upon methamphetamine induced neurotoxicity of the nigrostriatal dopaminergic system.
Gajjar TM; Anderson LI; Dluzen DE
J Neural Transm (Vienna); 2003 Nov; 110(11):1215-24. PubMed ID: 14628187
[TBL] [Abstract][Full Text] [Related]
20. Nomifensine alters sex differences in striatal dopaminergic function.
Poth LS; O'Connell BP; McDermott JL; Dluzen DE
Synapse; 2012 Aug; 66(8):686-93. PubMed ID: 22389194
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
